Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021
Federal Lawmakers Invest Big in COVID-19 Vaccine, Treatment Companies
Pfizer CEO tests positive for COVID for a second time | Reuters
Pfizer CEO Albert Bourla sold US$5.6 million stock on day of vaccine news
Why the Pfizer CEO selling 62% of his stock the same day as the vaccine announcement looks bad | Financial Post
Watchdog group calls for SEC probe: Pfizer CEO dumped $5.6M in stock on day of vaccine news | Salon.com
Pfizer's answer to tumbling stock is focusing on crowded cancer drug market | The Seattle Times
Pfizer Stock Down 40% in Past Year; CEO Bets on Cancer Drugs for Rebound - Bloomberg
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FJLGFF6UGBKJBBTST6Z5V2MT4I.jpg "Pfizer CEO calls US drug price plan 'negotiation with a gun to your head' | Reuters")
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head' | Reuters
Pfizer, the EU, and disappearing ink – POLITICO
Pfizer CEO made $5.6 million stock sale on same day as COVID-19 vaccine update: filing | Reuters
Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news | CNN Business
Pfizer CEO: 2023 will be a 'pivotal year' as COVID-19 drug sales wane
Coronavirus vaccine: Pfizer CEO sold $5.6 million of stock as company announced positive data
Pfizer's Covid Boost Crashes to Earth - WSJ
Pfizer CEO, CFO Sell $13 Million in Stock - Barron's
Pfizer CEO sold US$5.6M in stock the day he announced promising vaccine news | CTV News
Pfizer CEO Read to Step Aside at Year's End - WSJ
Pfizer CEO Joins Host of Executives at Covid-19 Vaccine Makers in Big Stock Sale - WSJ
Pfizer CEO sold $5.6-million of stock on day of COVID-19 vaccine update - The Globe and Mail
Pfizer CEO sold $5.5M in stock amid COVID-19 vaccine reveal
Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news | CNN Business
Pfizer Stock Is Falling. Did Investors Misunderstand the Revenue Guidance? - Barron's
Pfizer CEO Defends His Drug Firm's Shares
Pfizer Coronavirus Vaccine News Raises Questions About CEO's Stock Sales : NPR
Pfizer CEO Albert Bourla sold US$5.6 million stock on day of vaccine news
